Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Brauch

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Anticancer Research|March 1, 1995
Molecular genetic characterization of neuroendocrine lung cancer cell linesS L Lai, H Brauch, T Knutsen, et al.
Human Genetics|September 1, 1996
Mutations in the VHL tumor suppressor gene and associated lesions in families with von Hippel-Lindau disease from central EuropeD Glavac, H P Neumann, C Wittke, et al.
Genes, Chromosomes & Cancer|July 1, 1991
Involvement of the RAF1 locus, at band 3p25, in the 3p deletion of small-cell lung cancerS L Graziano, A M Pfeifer, J R Testa, et al.
Breast Cancer Research and Treatment|December 10, 2015
Clinical outcome and global gene expression data support the existence of the estrogen receptor-negative/progesterone receptor-positive invasive breast cancer phenotypeWerner Schroth, S Winter, F Büttner, et al.
Cancer Research|April 15, 2000
VHL alterations in human clear cell renal cell carcinoma: association with advanced tumor stage and a novel hot spot mutationH Brauch, G Weirich, J Brieger, et al.
Oncogene|May 18, 1999
Novel mutations of the MET proto-oncogene in papillary renal carcinomasL Schmidt, K Junker, N Nakaigawa, et al.
The Journal of Urology|September 29, 1998
Prevalence, morphology and biology of renal cell carcinoma in von Hippel-Lindau disease compared to sporadic renal cell carcinomaH P Neumann, B U Bender, D P Berger, et al.
The Pharmacogenomics Journal|August 6, 2014
Tamoxifen metabolism predicts drug concentrations and outcome in premenopausal patients with early breast cancerP Saladores, T Mürdter, D Eccles, et al.
Human Mutation|January 1, 1996
Germline mutations in the Von Hippel-Lindau disease (VHL) gene in families from North America, Europe, and JapanB Zbar, T Kishida, F Chen, et al.
Nature Genetics|May 1, 1997
Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomasL Schmidt, F M Duh, F Chen, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Anticancer Research|March 1, 1995
Molecular genetic characterization of neuroendocrine lung cancer cell linesS L Lai, H Brauch, T Knutsen, et al.
Human Genetics|September 1, 1996
Mutations in the VHL tumor suppressor gene and associated lesions in families with von Hippel-Lindau disease from central EuropeD Glavac, H P Neumann, C Wittke, et al.
Genes, Chromosomes & Cancer|July 1, 1991
Involvement of the RAF1 locus, at band 3p25, in the 3p deletion of small-cell lung cancerS L Graziano, A M Pfeifer, J R Testa, et al.
Breast Cancer Research and Treatment|December 10, 2015
Clinical outcome and global gene expression data support the existence of the estrogen receptor-negative/progesterone receptor-positive invasive breast cancer phenotypeWerner Schroth, S Winter, F Büttner, et al.
Cancer Research|April 15, 2000
VHL alterations in human clear cell renal cell carcinoma: association with advanced tumor stage and a novel hot spot mutationH Brauch, G Weirich, J Brieger, et al.
Oncogene|May 18, 1999
Novel mutations of the MET proto-oncogene in papillary renal carcinomasL Schmidt, K Junker, N Nakaigawa, et al.
The Journal of Urology|September 29, 1998
Prevalence, morphology and biology of renal cell carcinoma in von Hippel-Lindau disease compared to sporadic renal cell carcinomaH P Neumann, B U Bender, D P Berger, et al.
The Pharmacogenomics Journal|August 6, 2014
Tamoxifen metabolism predicts drug concentrations and outcome in premenopausal patients with early breast cancerP Saladores, T Mürdter, D Eccles, et al.
Human Mutation|January 1, 1996
Germline mutations in the Von Hippel-Lindau disease (VHL) gene in families from North America, Europe, and JapanB Zbar, T Kishida, F Chen, et al.
Nature Genetics|May 1, 1997
Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomasL Schmidt, F M Duh, F Chen, et al.
Pageof 8